gliozolamide TEMOZOLOMIDE

Introduction to gliozolamide

Gliozolamide is a medication primarily used in the form of tablets to treat certain aggressive brain tumors. Gliozolamide is effective against glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.

Composition of gliozolamide

Gliozolamide contains the active ingredient temozolomide, which is an alkylating agent. This compound works by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of gliozolamide

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of gliozolamide

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of gliozolamide

Patients should be aware that gliozolamide can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take gliozolamide

Gliozolamide is typically taken orally in tablet form. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's advice for the correct dosage and administration.

Conclusion of gliozolamide

Gliozolamide, containing the active ingredient temozolomide, belongs to the therapeutic class of alkylating agents. It is primarily used to treat aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Manufactured for effective cancer treatment, gliozolamide is a key medication in oncology. Always consult your healthcare provider for personalized medical advice.